Literature DB >> 7607658

Clinical phenotype of nephrogenic diabetes insipidus in females heterozygous for a vasopressin type 2 receptor mutation.

A F van Lieburg1, M A Verdijk, F Schoute, M J Ligtenberg, B A van Oost, F Waldhauser, M Dobner, L A Monnens, N V Knoers.   

Abstract

Nephrogenic diabetes insipidus (NDI) usually shows an X-linked recessive mode of inheritance caused by mutations in the vasopressin type 2 receptor gene (AVPR2). In the present study, three NDI families are described in which females show clinical features resembling the phenotype in males. Maximal urine osmolality in three female patients did not exceed 200 mosmol/kg and the absence of extra-renal responses to 1-desamino-8-D-arginine vasopressin was demonstrated in two of them. All affected females and two asymptomatic female family members were shown to be heterozygous for an AVPR2 mutation. Skewed X-inactivation is the most likely explanation for the clinical manifestation of NDI in female carriers of an AVPR2 mutation. It is concluded that, in female NDI patients, the possibility of heterozygosity for an AVPR2 gene mutation has to be considered in addition to homozygosity for mutations in the aquaporin 2 gene.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7607658     DOI: 10.1007/BF00214189

Source DB:  PubMed          Journal:  Hum Genet        ISSN: 0340-6717            Impact factor:   4.132


  29 in total

1.  [FAMILIAL NEPHROGENIC DIABETES INSIPIDUS FULLY DEVELOPED IN A FEMALE INFANT].

Authors:  J BRODEHL; L BRAUN
Journal:  Klin Wochenschr       Date:  1964-06-15

2.  Inheritance of vasopressin-resistant ("nephrogenic") diabetes insipidus.

Authors:  M G ROBINSON; S A KAPLAN
Journal:  AMA J Dis Child       Date:  1960-02

3.  The carrier state in nephrogenic diabetes insipidus.

Authors:  C CARTER; M SIMPKISS
Journal:  Lancet       Date:  1956-11-24       Impact factor: 79.321

4.  Fibrinolytic responses to 1-desamino-8-D-arginine-vasopressin in patients with congenital nephrogenic diabetes insipidus.

Authors:  N Knoers; E J Brommer; H Willems; B A van Oost; L A Monnens
Journal:  Nephron       Date:  1990       Impact factor: 2.847

5.  The molecular basis of severe hemophilia B in a girl.

Authors:  P Nisen; J Stamberg; R Ehrenpreis; S Velasco; A Shende; J Engelberg; G Karayalcin; L Waber
Journal:  N Engl J Med       Date:  1986-10-30       Impact factor: 91.245

6.  Congenital nephrogenic diabetes insipidus in a baby girl.

Authors:  R L Schreiner; P R Skafish; S K Anand; J D Northway
Journal:  Arch Dis Child       Date:  1978-11       Impact factor: 3.791

7.  Hemodynamic and coagulation responses to 1-desamino[8-D-arginine] vasopressin in patients with congenital nephrogenic diabetes insipidus.

Authors:  D G Bichet; M Razi; M Lonergan; M F Arthus; V Papukna; C Kortas; J N Barjon
Journal:  N Engl J Med       Date:  1988-04-07       Impact factor: 91.245

8.  Nephrogenic diabetes insipidus in a Negro kindred.

Authors:  R D Feigin; D L Rimoin; R L Kaufman
Journal:  Am J Dis Child       Date:  1970-07

9.  X-linked nephrogenic diabetes insipidus mutations in North America and the Hopewell hypothesis.

Authors:  D G Bichet; M F Arthus; M Lonergan; G N Hendy; A J Paradis; T M Fujiwara; K Morgan; M C Gregory; W Rosenthal; A Didwania
Journal:  J Clin Invest       Date:  1993-09       Impact factor: 14.808

10.  Requirement of human renal water channel aquaporin-2 for vasopressin-dependent concentration of urine.

Authors:  P M Deen; M A Verdijk; N V Knoers; B Wieringa; L A Monnens; C H van Os; B A van Oost
Journal:  Science       Date:  1994-04-01       Impact factor: 47.728

View more
  6 in total

1.  Generation and phenotype of mice harboring a nonsense mutation in the V2 vasopressin receptor gene.

Authors:  J Yun; T Schöneberg; J Liu; A Schulz; C A Ecelbarger; D Promeneur; S Nielsen; H Sheng; A Grinberg; C Deng; J Wess
Journal:  J Clin Invest       Date:  2000-12       Impact factor: 14.808

2.  Treatment of nephrogenic diabetes insipidus with hydrochlorothiazide and amiloride.

Authors:  V Kirchlechner; D Y Koller; R Seidl; F Waldhauser
Journal:  Arch Dis Child       Date:  1999-06       Impact factor: 3.791

3.  Hereditary nephrogenic diabetes insipidus in Japanese patients: analysis of 78 families and report of 22 new mutations in AVPR2 and AQP2.

Authors:  Sei Sasaki; Motoko Chiga; Eriko Kikuchi; Tatemitsu Rai; Shinichi Uchida
Journal:  Clin Exp Nephrol       Date:  2012-11-14       Impact factor: 2.801

4.  A novel deletion mutation in the arginine vasopressin receptor 2 gene and skewed X chromosome inactivation in a female patient with congenital nephrogenic diabetes insipidus.

Authors:  K Kinoshita; Y Miura; H Nagasaki; T Murase; Y Bando; Y Oiso
Journal:  J Endocrinol Invest       Date:  2004-02       Impact factor: 4.256

5.  Nephrogenic diabetes insipidus (NDI): clinical, laboratory and genetic characterization of five Brazilian patients.

Authors:  Maria Helena Vaisbich; Juliana Carneiro; Wolfanga Bóson; Bruna Resende; Luiz De Marco; Rachel S Honjo; Chong Ae Kim; Vera H Koch
Journal:  Clinics (Sao Paulo)       Date:  2009-05       Impact factor: 2.365

6.  Immunological profile in a family with nephrogenic diabetes insipidus with a novel 11 kb deletion in AVPR2 and ARHGAP4 genes.

Authors:  Masaya Fujimoto; Kohsuke Imai; Kenji Hirata; Reiichi Kashiwagi; Yoichi Morinishi; Katsuhiko Kitazawa; Sei Sasaki; Tadao Arinami; Shigeaki Nonoyama; Emiko Noguchi
Journal:  BMC Med Genet       Date:  2008-05-20       Impact factor: 2.103

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.